SCHEMBL7613643

SCHEMBL7613643

CCCCOC(=O)c1ccc([N+](=O)[O-])c(CN(C)C(=O)CO)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.49
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 4/20 0.44
MAPT P10636 2/20 0.44
RAB9A P51151 2/20 0.44
PKM P14618 2/20 0.44
NPC1 O15118 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
LMNA P02545 5/20 0.43
CYP1A2 P05177 2/20 0.43
TSHR P16473 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP2D6 P10635 1/20 0.43
MAPK1 P28482 1/20 0.43
NR1H2 P55055 1/20 0.43
RNASEL Q05823 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6378374 0.81 KMT2A (0.42) KMT2AMEN1ALDH1A1MAPTRAB9A
SCHEMBL6378830 0.80 CASP6 (0.53) LMNATSHRPOLB
SCHEMBL6956090 0.78 ESR1 (0.60) ESR1KMT2AALDH1A1MAPTRAB9A
SCHEMBL17287371 0.77 ESR1 (0.58) ESR1KMT2AMEN1ALDH1A1MAPT
SCHEMBL29556431 0.77 ESR1 (0.57) ESR1KMT2AALDH1A1MAPTRAB9A
SCHEMBL11495159 0.77 ESR1 (0.57) ESR1ALDH1A1MAPTRAB9APKM
SCHEMBL3647689 0.75 ESR1 (0.66) ESR1KMT2AALDH1A1MAPTRAB9A
SCHEMBL27583159 0.75 KMT2A (0.53) KMT2AMEN1ALDH1A1MAPTRAB9A
SCHEMBL16466482 0.75 KMT2A (0.63) ESR1KMT2AMEN1ALDH1A1MAPT
SCHEMBL17287403 0.74 ESR1 (0.61) ESR1KMT2AALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1225895-A4 FAB I INHIBITORS SMITHKLINE BEECHAM CORP (US) 2002-11-13 EP disclosed
EP-1225895-A1 FAB I INHIBITORS SmithKline Beecham Corporation (US) 2002-07-31 EP disclosed
WO-2001026654-A1 FAB I INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-04-19 WO disclosed